|
Volumn 358, Issue 9291, 2001, Pages 1383-1385
|
Learning from the cerivastatin experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 HYDROXY 3 METHYLGLUTARYL COENZYME A;
ATORVASTATIN;
CERIVASTATIN;
CREATINE KINASE;
CYTOCHROME P450;
FLUINDOSTATIN;
GEMFIBROZIL;
MEVINOLIN;
PRAVASTATIN;
SIMVASTATIN;
UBIQUINONE;
ATHEROSCLEROSIS;
CHOLESTEROL BLOOD LEVEL;
CHOLESTEROL METABOLISM;
CHOLESTEROL SYNTHESIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG METABOLISM;
DRUG STRUCTURE;
ENZYME METABOLISM;
HUMAN;
HYDROPHILICITY;
IN VITRO STUDY;
LIPID SOLUBILITY;
LIVER CELL;
MUSCLE CELL;
MYALGIA;
MYOBLAST;
MYOSITIS;
NOTE;
PRIORITY JOURNAL;
RHABDOMYOLYSIS;
|
EID: 0035960430
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(01)06489-3 Document Type: Note |
Times cited : (113)
|
References (14)
|